Adriana Olar

Summary

Affiliation: The Methodist Hospital
Country: USA

Publications

  1. doi request reprint Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults
    Adriana Olar
    Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, TX, USA
    Ann Diagn Pathol 16:161-70. 2012
  2. doi request reprint Biomarkers classification and therapeutic decision-making for malignant gliomas
    Adriana Olar
    Department of Pathology and Genomic Medicine, The Methodist Hospital, 6565 Fannin St, M227, Houston, TX 77030, USA
    Curr Treat Options Oncol 13:417-36. 2012
  3. doi request reprint Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma
    Aditya Raghunathan
    Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, 77030, USA
    Ann Diagn Pathol 16:255-9. 2012
  4. doi request reprint Using the molecular classification of glioblastoma to inform personalized treatment
    Adriana Olar
    Department of Pathology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA
    J Pathol 232:165-77. 2014

Detail Information

Publications4

  1. doi request reprint Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults
    Adriana Olar
    Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, TX, USA
    Ann Diagn Pathol 16:161-70. 2012
    ..The shorter interval of progression and negative IDH1-R132H mutation status suggest a similar molecular pathway as seen in primary GBM...
  2. doi request reprint Biomarkers classification and therapeutic decision-making for malignant gliomas
    Adriana Olar
    Department of Pathology and Genomic Medicine, The Methodist Hospital, 6565 Fannin St, M227, Houston, TX 77030, USA
    Curr Treat Options Oncol 13:417-36. 2012
    ....
  3. doi request reprint Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma
    Aditya Raghunathan
    Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, 77030, USA
    Ann Diagn Pathol 16:255-9. 2012
    ..The absence of mutant IDH1 R132H protein expression in AG may help further distinguish this unique neoplasm from diffuse glioma...
  4. doi request reprint Using the molecular classification of glioblastoma to inform personalized treatment
    Adriana Olar
    Department of Pathology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA
    J Pathol 232:165-77. 2014
    ..In this paper we review basic glioblastoma pathophysiology, with emphasis on clinically relevant genetic molecular alterations and potential targets for further drug development...